Research Rheum

Lactoferricin’s Role in Preventing Disc Degeneration

Lara C. Pullen, PhD | September 16, 2013

The combination of bone-morphogenetic protein-7 (BMP7) and lactoferricin B (LfcinB) may be a useful treatment for disc degeneration. (posted Sept. 16, 2013)

Sensory Nerves May Be Key for Osteoporosis

Lara C. Pullen, PhD | September 10, 2013

Sensory nerves have an essential role in bone remodeling. In particular, semaphorin 3A (Sema3A) regulates bone remodeling by modulating sensory nerve development. (posted Sept. 9, 2013)

Rheumatology Research Foundation Announces 2013 Awards and Grants Recipients

Staff | September 1, 2013

The Foundation names winners of education and training awards, career development research awards, and disease-targeted research grants

ACR Research Conferences to Focus on Rheumatic Diseases

Staff | September 1, 2013

The ACR’s Basic Research Conference and Clinical Research Conference on October 25–26 to feature new perspectives on development of rheumatoid arthritis, lupus, and vasulitis, and review current thinking on preclinical rheumatic disease

EULAR 2013: Research Hints at Risk Factors for Rheumatoid Arthritis

Thomas R. Collins | September 1, 2013

Studies point to involvement of anti-CCP antibodies and citrullinated targets in the lungs and joints in the development of RA, and suggest an early therapeutic window for prevention

New Methodology to Improve Cartilage Repair

Lara C. Pullen, PhD | July 31, 2013

A single treatment with recombinant acid ceramidase improves the chondrogenic phenotype of primary chondrocytes and leads to an increased yield of mesenchymal stem cells. (posted July 31, 2013)

B-Cell Genes Interact to Increase Risk for Rheumatoid Arthritis

Lara C. Pullen, PhD | July 31, 2013

Researchers demonstrate that BANK1 is a susceptibility gene for RA, and it may play a role in RA pathogenesis. (posted June 31, 2013)

Rheumatology Drug Research Should Focus on Particular Groups of Patients

Deborah Levenson | July 1, 2013

An analysis of risks and benefits of drugs in specific types of patients will help rheumatologists provide better treatment

California Rheumatology Alliance 2013 Meeting: The Future of Rheumatoid Arthritis

Stephanie Cajigal | July 1, 2013

Treatment for RA should involve targeting subclinical disease and reversing immune dysregulation, expert says

Researchers Explore HLA-B27’s Role in the Development of Spondylitis

Will O’Brien, MD | June 14, 2013

New research reports on the increased sensitivity of human-HLA-B27 transgenic rat bone marrow monocytes to TNF-α stimulation and osteoclast differentiation. (posted June 27, 2013)